The Ministry of Health and Family Welfare has unveiled two major frameworks — SAHI and BODH — to strengthen the secure, evidence‑based deployment of artificial intelligence in the country’s health ecosystem. Key Developments (17 Feb 2026) Launch of SAHI at the India AI Impact Summit, providing a national guidance framework for safe, ethical, and inclusive AI adoption in healthcare. Introduction of BODH , a partnership with IIT Kanpur , offering a structured platform to test and validate AI solutions before large‑scale rollout. Integration of AI tools through the ABDM sandbox, enabling developers to trial AI screening tools in a controlled environment. Reaffirmation by Union Minister of State for Health and Family Welfare Smt. Anupriya Patel in the Rajya Sabha, emphasizing the government’s commitment to secure AI in health. Regulatory Landscape The CDSCO oversees a comprehensive regulatory pathway for all medical devices, including AI‑enabled ones, under the Medical Devices Rules, 2017 . Applicants must submit detailed technical documentation covering: Essential Principles Checklist to demonstrate conformity with safety and performance norms. Verification and validation reports, including software testing. Risk analysis and mitigation documents. Clinical evidence substantiating safety, performance, and effectiveness. Quality Management System (QMS) records. Software version release certificates, where applicable. Chapters IV and V of the Rules prescribe timelines for granting manufacturing and import licences, ensuring a clear pathway from development to market. Important Facts SAHI focuses on ethical AI, data privacy, bias mitigation, and inclusivity across public and private health providers. BODH offers open datasets, benchmarking metrics, and a validation sandbox to assess algorithmic accuracy, robustness, and fairness. The ABDM sandbox facilitates seamless integration of AI tools with national health identifiers, electronic health records, and tele‑medicine platforms. Regulatory compliance under the Medical Devices Rules, 2017 remains mandatory for AI‑enabled diagnostic and therapeutic devices. UPSC Relevance Understanding these initiatives is crucial for GS 2 (Polity) and GS 3 (Technology & Governance) papers. Aspirants should note: How the government balances innovation with safety through policy frameworks like SAHI and regulatory oversight by CDSCO . The role of public‑private partnerships (e.g., with IIT Kanpur ) in building technical infrastructure. Implications for health security, data privacy, and equitable access—key themes in Ethics (GS 4) and Governance. Way Forward For effective implementation, the government must: Continuously update SAHI guidelines to incorporate emerging AI risks and international best practices. Scale the BODH platform to include more diverse datasets, ensuring algorithmic fairness across regions and populations. Strengthen capacity building for regulators and healthcare providers to interpret AI validation reports and manage post‑market surveillance. Promote interdisciplinary research linking AI ethics, clinical outcomes, and public health policy. These steps will help India harness AI’s potential while safeguarding patient safety and public trust.